We combine ethics, expertise, and leadership to deliver measurable sustainability impact that drives lasting benefits for communities, the environment, and the world.
Ethics, sustainability, and governance are at the heart of everything we do, reflected in our commitments to B Corp, EcoVadis, SBTi, and ISO9001.
Sustainability shapes our decisions and how we work with partners, ensuring our impact goes beyond individual projects. We measure our own carbon and energy reductions, maintain transparency, and focus on building a resilient, efficient business that drives lasting positive change across the industry. By aligning with SBTi’s science-based targets, our strategies support global climate goals while addressing the unique challenges of pharmaceutical and life sciences organisations.
Our accreditations reflect a commitment to doing business responsibly and to the highest standards and delivering better outcomes for our clients.
As a certified B Corp and EcoVadis-rated organisation, we are independently benchmarked against global standards for sustainability, transparency, and accountability.
ISO9001 certification ensures quality management is embedded in every project we deliver, giving clients confidence in both our processes and outcomes.
Our alignment with SBTi ensures our own commitments contribute to meaningful, long-term carbon reduction.
We’re driving a shift in how the pharmaceutical and life sciences industry defines and delivers responsible progress, setting higher expectations for sustainability, transparency, and performance that create lasting value for businesses, society, and the environment.
These frameworks reinforce our role as a trusted partner, proving that the values we promote are lived through measurable action and governance in everything we do.
Across the pharmaceutical and life sciences industry, Scope 3 is becoming one of the most pressing questions. While managing Scope 1 and 2 emissions remains essential, it is increasingly clear that the biggest share of emissions often lies within the supply chain and other indirect impacts.
We recognise this shift and are actively working with clients to address it. Through our methodologies, we help organisations map and understand the scale of Scope 3 emissions, engage suppliers and partners in meaningful reduction efforts, and embed Scope 3 into wider sustainability strategies.
By tackling Scope 3 directly, we help clients take control of their supply chain and make real progress towards Net Zero.
EECO2 is an active contributor to the International Society for Pharmaceutical Engineering (ISPE), helping shape best practice for energy efficiency and sustainability in highly regulated environments.
Through collaboration, knowledge-sharing, and thought leadership, we ensure that our clients benefit from the latest innovations and standards in sustainable facility design and operation.
Our impact goes beyond individual projects. Through our ethical commitments, global accreditations, and industry leadership, we are helping set a new standard for sustainability in the pharmaceutical and life sciences industry.
© Copyright 2025 EECO2
Created by Summit Creative
